3-(bis(2-hydroxyethyl)sulfamoyl)benzoic acid
ADVERTISEMENT
- Molecular formula
- C11H15NO5S
- CAS Number
- 78475-49-1
- IUPAC Name
- 3-[bis(2-hydroxyethyl)sulfamoyl]benzoic acid
- Molecular Weight
- 259.27g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.4900g/cm3
- Synonyms
- 3-[bis(2-hydroxyethyl)sulfamoyl]benzoic acid
Identification
Interesting facts
Interesting Facts about 3-[bis(2-hydroxyethyl)sulfamoyl]benzoic Acid
3-[bis(2-hydroxyethyl)sulfamoyl]benzoic acid is a fascinating compound with a range of applications in various fields of chemistry and biochemistry. Here are some engaging facts about this intriguing molecule:
- Functional Versatility: This compound features a sulfonamide functional group, which imparts unique properties, allowing it to be utilized in medicinal chemistry for drug development, especially in the design of antibiotics.
- Hydrophilic Nature: The presence of two hydroxyethyl groups contributes to its hydrophilicity, enhancing its solubility in water. This feature is particularly beneficial for biological applications where solubility in biological fluids is critical.
- Role in Biochemistry: Compounds like this one are often studied for their interactions with various biological targets, including enzymes and receptors, making them important in the field of pharmacology.
- Potential Antimicrobial Activity: The sulfamoyl moiety can exhibit activity against a variety of microbes. Researchers continue to explore its efficacy against resistant strains of bacteria, making it a compound of interest for public health.
- Applications in Polymer Chemistry: This compound can also serve as a building block for the synthesis of polymers, especially those designed for drug delivery systems, improving the bioavailability of therapeutic agents.
Overall, 3-[bis(2-hydroxyethyl)sulfamoyl]benzoic acid is a prime example of how organic chemistry can intersect with numerous scientific domains, highlighting the importance of interdisciplinary research in the pursuit of novel solutions to medical challenges.